Douglas N. Durand
Fondatore presso Durand Venture Associates LLC
Posizioni attive di Douglas N. Durand
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Oligomerix, Inc.
 Oligomerix, Inc. Drugstore ChainsRetail Trade Oligomerix, Inc. develops novel therapeutics and diagnostic assays for alzheimer diseases. It is a biopharmaceutical company focused on the discovery and development of small molecule inhibitors, immunotherapeutic approaches and biomarkers targeting tau oligomers. The firm's platform is based on small neurotoxic aggregates of proteins such as tau oligomers, an important target for AD and other tauopathies characterized by the progressive accumulation of tau aggregates. The company was founded by James G. Moe, Eliot J. Davidowitz, Ishita Chatterjee and Pedro M. Rojas in 2006 and is headquartered in New York, NY. | Direttore/Membro del Consiglio | - | - |
Durand Venture Associates LLC
 Durand Venture Associates LLC Financial ConglomeratesFinance Durand Venture Associates LLC operates as a venture capital firm. The company was founded by Douglas N. Durand and is headquartered in Wilmington, DE. | Fondatore | - | - |
| Corporate Officer/Principal | - | - |
Storia della carriera di Douglas N. Durand
Precedenti posizioni note di Douglas N. Durand
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| AstraZeneca Diagnostics | Vendite & Marketing | - | - |
| MERCK & CO., INC. | Vendite & Marketing | - | - |
| Astra Pharmaceuticals, Inc. | Vendite & Marketing | - | - |
Statistiche
Distribuzione geografica
| Stati Uniti | 6 |
Posizioni
| Sales & Marketing | 3 |
| Director/Board Member | 1 |
| Founder | 1 |
Settori
| Retail Trade | 2 |
| Health Technology | 2 |
| Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| Aziende private | 4 |
|---|---|
Oligomerix, Inc.
Oligomerix, Inc. Drugstore ChainsRetail Trade Oligomerix, Inc. develops novel therapeutics and diagnostic assays for alzheimer diseases. It is a biopharmaceutical company focused on the discovery and development of small molecule inhibitors, immunotherapeutic approaches and biomarkers targeting tau oligomers. The firm's platform is based on small neurotoxic aggregates of proteins such as tau oligomers, an important target for AD and other tauopathies characterized by the progressive accumulation of tau aggregates. The company was founded by James G. Moe, Eliot J. Davidowitz, Ishita Chatterjee and Pedro M. Rojas in 2006 and is headquartered in New York, NY. | Retail Trade |
| Astra Pharmaceuticals, Inc. | |
| AstraZeneca Diagnostics | |
Durand Venture Associates LLC
Durand Venture Associates LLC Financial ConglomeratesFinance Durand Venture Associates LLC operates as a venture capital firm. The company was founded by Douglas N. Durand and is headquartered in Wilmington, DE. | Finance |
- Borsa valori
- Insiders
- Douglas N. Durand
- Esperienza
